Latest News
Moderna accelerates Covid-19 vaccine shipments to US for Q2 and Q3
Moderna is accelerating shipments of its Covid-19 vaccine to the US federal government as the country races to head off the pandemic.
GSK, Vir to collaborate on new therapeutics for flu
GlaxoSmithKline and Vir Biotechnology will expand their existing collaboration to include the research and development of new therapies for influenza and other respiratory viruses.
FCA says could veto Woodford comeback
The City regulator has cast doubt on Neil Woodford's comeback by saying it could veto the fallen star fund manager's attempt to relaunch his career.
Moderna to supply EU with additional 150m doses of its Covid vaccine
The European Commission has purchased an additional 150m doses of Moderna’s Covid-19 vaccine, due to be delivered in the third and fourth quarter of the year.
Credit Suisse's Golub says rising Treasury yields are a 'positive' for Wall Street
The rise in government bond yields and narrowing credit spreads are a signal that the economy is on the mend, a good omen for stocks, Credit Suisse strategist Jonathan Golub said.
Transense Technologies swings to profit in first half
Sensor systems developer Transense Technologies reported a threefold improvement in revenue from continuing operations in its first half on Wednesday, to £0. 9m.
Europe open: Shares slide as rally loses momentum
European shares opened lower on Wednesday as the rally of recent days ran out of steam.
Pebble Beach cuts costs as pandemic impacts revenue
Broadcast and streaming automation and content management technology company Pebble Beach said on Wednesday that it expected to report results for 2020 with revenue of around £8. 4m, down from £11. 2m, and adjusted EBITDA of £2. 6m, falling from £3. 8m.
Gucci owner Kering see FY sales drop as Covid travel bans hit stores
Gucci owner Kering reported a fall in full-year sales as Covid-19 travel restrictions kept customers from its luxury stores, but signalled a recovery in the second half.
Covid lockdowns impact Gattaca in first half
Engineering and technology recruitment specialist Gattaca updated the market on its first half on Wednesday, saying it was expecting net fee income of £21. 1m, down from £31. 8m year-on-year.
Sweden's Sinch expands into US with $1.14bn Inteliquent deal
Swedish cloud computing services provider Sinch said on Wednesday it was buying US communications company Inteliquent for $1. 14bn.
US pre-open: Futures mixed, Dow on track to narrowly extend gains
Wall Street futures were mixed ahead of the bell on Wednesday after the Dow Jones hit yet another all-time high in the previous session.
Leeds Group seeks German government help
Leeds Group said it had asked for financial aid from the German government because the country's extension of Covid-19 restrictions threatened to have a big impact on trading.
Europe midday: Inflation fears send shares lower
European shares opened lower on Wednesday as the rally of recent days ran out of steam amid worries over rising prices fuelling inflation and hindering any post-Covid economic recovery.
London midday: Stocks a little weaker as inflation ticks higher
London stocks were still a little weaker by midday Wednesday as investors mulled an unexpected uptick in UK inflation.
Ryanair to appeal EU court rulings on French, Swedish state aid
Ryanair on Wednesday said it was appealing against a European court ruling in favour of state aid for rivals Air France and SAS.
Companies prepare 'no-jab, no-job' contracts - report
UK companies are preparing to present employees with "no jab, no job" contracts as the government conceded it was up to businesses to decide on the measure, the Financial Times reported.
Greencoat UK Wind raises £198m from placing
Renewable infrastructure fund Greencoat UK Wind said on Wednesday that it had raised gross proceeds of £198. 0m on the back of a placing of new ordinary shares.
Citi says a correction on Wall Street 'very likely'
A so-called 'correction' on Wall Street is increasingly likely now that the risk-reward offered by shares has turned 'neutral', Citigroup said.
Silence Therapeutics begins dosing in lipoprotein treatment trial
Silence Therapeutics has started dosing subjects in the ‘APOLLO’ phase 1 clinical study of its wholly-owned lead product candidate ‘SLN360’, it announced on Wednesday, for the treatment of elevated lipoprotein-a (Lp(a)) levels.